Molecular mechanism of shikonin inhibiting tumor growth and potential application in cancer treatment

Shikonin is one of the major bioactive components of . It has a good killing effect in a variety of tumor cells. Its antitumor effect involves multiple targets and pathways and has received extensive attention and study in recent years. In this review, we systematically review recent progress in det...

Full description

Saved in:
Bibliographic Details
Published in:Toxicology research (Cambridge) 2021-12, Vol.10 (6), p.1077-1084
Main Authors: Wang, Qiang, Wang, Jing, Wang, Jiayou, Ju, Xiaoli, Zhang, Heng
Format: Article
Language:English
Subjects:
Review
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Shikonin is one of the major bioactive components of . It has a good killing effect in a variety of tumor cells. Its antitumor effect involves multiple targets and pathways and has received extensive attention and study in recent years. In this review, we systematically review recent progress in determining the antitumor mechanism of shikonin and its derivatives, specifically their induction of reactive oxygen species production, inhibition of EGFR and PI3K/AKT signaling pathway activation, inhibition of angiogenesis and induction of apoptosis and necroptosis. We also discuss the application of nanoparticles loaded with shikonin in the targeted therapy of various cancers. Finally, we suggest new strategies for the clinical application of shikonin and its derivatives.
ISSN:2045-452X
2045-4538
2045-4538
DOI:10.1093/toxres/tfab107